{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:06:35Z","timestamp":1778058395236,"version":"3.51.4"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education","award":["2020R1F1A1053663"],"award-info":[{"award-number":["2020R1F1A1053663"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Breast cancer in women is one of the most common life-threatening malignancies. Despite of the development for the improved treatment, there are still many limitations to overcome. Among them, cancer stem cells (CSCs) are well known for tumor formation, development, cellular heterogeneity, and cancer recurrence. Therefore, to completely cure breast cancer, treatment of both cancer and CSC is required. To selectively target CSCs, we generated a liposome-based smart nano complex using CEACAM 6 (CD66c) antibody (Ab), a novel cell-surface biomarker of breast-derived CSCs (BCSCs) discovered in our previous research. Selective and increased cellular uptake was observed in BCSCs treated with CD66c Ab-conjugated rhodamine-labeled liposomes (CDRHOL) depending on the expression level of CD66c. CD66c Ab-conjugated doxorubicin (DOX)-loaded liposomes (CDDOXL) selectively showed increased cell killing effects in BCSCs with high CD66c expression levels. In an in vivo animal study, CDRHOL showed enhanced accumulation in xenografted BCSC tumors with low delivery into non-target organs. Moreover, mice treated with CDDOXL have assessed the decreased induction ability of immune response by low expression levels of pro-inflammatory cytokines and reduced liver toxicity by histopathological analysis. Finally, the improved antitumor effect of CDDOXL was evaluated in a metastatic BCSC mouse model via systemic administration. Collectively, our study is the first to demonstrate that a multi-functional nano complex using a novel surface biomarker of BCSC may be a more effective therapeutic agent for the treatment of cancer and CSCs.<\/jats:p>","DOI":"10.3390\/ijms24010685","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T04:07:09Z","timestamp":1672632429000},"page":"685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3119-3285","authenticated-orcid":false,"given":"Eun-Young","family":"Koh","sequence":"first","affiliation":[{"name":"Department of Biomedical Laboratory Science, Konyang University, Daejeon 35365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun-Sik","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Laboratory Science, Konyang University, Daejeon 35365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Bin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Biomedical Laboratory Science, Konyang University, Daejeon 35365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0998-5569","authenticated-orcid":false,"given":"Jong-Seok","family":"Kim","sequence":"additional","affiliation":[{"name":"Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-4025","authenticated-orcid":false,"given":"Pyung-Hwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Laboratory Science, Konyang University, Daejeon 35365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4048\/jbc.2018.21.1.1","article-title":"Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry","volume":"21","author":"Kang","year":"2018","journal-title":"J. Breast Cancer"},{"key":"ref_2","first-page":"13","article-title":"Overview of breast cancer","volume":"32","author":"Watkins","year":"2019","journal-title":"J. Am. Acad. Physician Assist."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","article-title":"Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets","volume":"60","author":"Liang","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/stem.2579","article-title":"Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells","volume":"35","author":"Ahmed","year":"2017","journal-title":"Stem Cells"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Ginestier","year":"2009","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00018-016-2334-7","article-title":"Breast cancer stem cell: The roles and therapeutic implications","volume":"74","author":"Yang","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2015.12.001","article-title":"Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways","volume":"158","author":"Leon","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"44191","DOI":"10.18632\/oncotarget.6176","article-title":"Cancer stem cell targeted therapy: Progress amid controversies","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5483\/BMBRep.2017.50.3.222","article-title":"Cancer stem cell heterogeneity: Origin and new perspectives on CSC targeting","volume":"50","author":"Eun","year":"2017","journal-title":"BMB Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: A systematic review","volume":"13","author":"Muhamad","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_11","first-page":"315","article-title":"Chemical Proteomic Approaches Targeting Cancer Stem Cells: A Review of Current Literature","volume":"14","author":"Jung","year":"2017","journal-title":"Cancer Genom. Proteom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2015.10.044","article-title":"Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin","volume":"220","author":"Arabi","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.15283\/ijsc19006","article-title":"Application of Nanotechnology in Targeting of Cancer Stem Cells: A Review","volume":"12","author":"Asghari","year":"2019","journal-title":"Int. J. Stem. Cells"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.7150\/thno.20771","article-title":"Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly","volume":"7","author":"Lin","year":"2017","journal-title":"Theranostics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/bjc.2014.105","article-title":"Lack of correlation of stem cell markers in breast cancer stem cells","volume":"110","author":"Liu","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Palomeras, S., Ruiz-Martinez, S., and Puig, T. (2018). Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance. Molecules, 23.","DOI":"10.3390\/molecules23092193"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Olusanya, T.O.B., Haj Ahmad, R.R., Ibegbu, D.M., Smith, J.R., and Elkordy, A.A. (2018). Liposomal Drug Delivery Systems and Anticancer Drugs. Molecules, 23.","DOI":"10.3390\/molecules23040907"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: From concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bulbake, U., Doppalapudi, S., Kommineni, N., and Khan, W. (2017). Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics, 9.","DOI":"10.3390\/pharmaceutics9020012"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.addr.2006.03.007","article-title":"Current status of polymeric gene delivery systems","volume":"58","author":"Park","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","article-title":"Molecular targeted therapy: Treating cancer with specificity","volume":"834","author":"Lee","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_23","first-page":"384","article-title":"Biological Functions and Identification of Novel Biomarker Expressed on the Surface of Breast Cancer-Derived Cancer Stem Cells via Proteomic Analysis","volume":"43","author":"Koh","year":"2020","journal-title":"Mol. Cells"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/acs.jafc.6b04975","article-title":"Pharmacokinetics and Biodistribution of the Illegal Food Colorant Rhodamine B in Rats","volume":"65","author":"Cheng","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"ref_25","first-page":"3269","article-title":"Bioactive nanotherapeutic trends to combat triple negative breast cancer","volume":"6","author":"Chowdhury","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1038\/ncomms10068","article-title":"PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype","volume":"6","author":"Duan","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr1982","article-title":"Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy","volume":"10","author":"Fillmore","year":"2008","journal-title":"Breast Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5108653","DOI":"10.1155\/2017\/5108653","article-title":"The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy","volume":"2017","author":"Xiao","year":"2017","journal-title":"Anal. Cell. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cjp2.91","article-title":"Biomarker discovery for renal cancer stem cells","volume":"4","author":"Corro","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/09553002.2013.873559","article-title":"Proteomics of cancer stem cells","volume":"90","author":"Skvortsov","year":"2014","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Badrinath, N., and Yoo, S.Y. (2019). Recent Advances in Cancer Stem Cell-Targeted Immunotherapy. Cancers, 11.","DOI":"10.3390\/cancers11030310"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.115.012070","article-title":"Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come","volume":"68","author":"Yingchoncharoen","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/pmic.201500002","article-title":"A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations","volume":"15","author":"Nie","year":"2015","journal-title":"Proteomics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/carcin\/bgh261","article-title":"Modeling metastasis in vivo","volume":"26","author":"Khanna","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_36","first-page":"302","article-title":"Seed and soil: A conceptual framework of metastasis for clinicians","volume":"110","author":"Faraji","year":"2013","journal-title":"Mo. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Oh, H.R., Jo, H.Y., Park, J.S., Kim, D.E., Cho, J.Y., Kim, P.H., and Kim, K.S. (2016). Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin\/Vimentin siRNA to Hepatocellular Carcinoma. Nanomaterials, 6.","DOI":"10.3390\/nano6080141"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42826-020-00048-y","article-title":"Two base pair deletion in IL2 receptor \u03b3 gene in NOD \/SCID mice induces a highly severe immunodeficiency","volume":"36","author":"Bak","year":"2020","journal-title":"Lab. Anim. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/685\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:48:42Z","timestamp":1760147322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24010685"],"URL":"https:\/\/doi.org\/10.3390\/ijms24010685","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}